Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Treasury Shares (2019 - 2025)

Cellebrite DI has reported Treasury Shares over the past 6 years, most recently at $85000.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $85000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $85000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $85000.0, changed 0.0%.
  • Treasury Shares for Q4 2025 was $41776.0 at Cellebrite DI, down from $7.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for CLBT hit a ceiling of $8.2 million in Q4 2023 and a floor of $41776.0 in Q4 2021.
  • Median Treasury Shares over the past 5 years was $6.4 million (2022), compared with a mean of $4.4 million.
  • Peak annual rise in Treasury Shares hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Cellebrite DI's Treasury Shares stood at $85000.0 in 2021, then changed by 0.0% to $85000.0 in 2022, then changed by 0.0% to $85000.0 in 2023, then changed by 0.0% to $85000.0 in 2024, then changed by 0.0% to $85000.0 in 2025.
  • The last three reported values for Treasury Shares were $85000.0 (Q4 2025), $85000.0 (Q4 2024), and $85000.0 (Q4 2023) per Business Quant data.